Company intelligence / Profile preview

SIS Ventures Impact Investors

Edinburgh, Scotland, United Kingdom

Ownership: Private
Development stage: Other

Overview

SIS Ventures is an active social impact venture capital/impact investor fund focused on early-stage high-impact enterprises, particularly in Scotland. While it invests in companies spanning various sectors—including life sciences, medical technology, and biotechnology—it does not directly develop therapeutics or medical products itself. It has invested over £5.6 million in 14 companies, many working on healthcare innovations such as early diagnostics for cancer and neurodegenerative diseases, but the fund itself is not a biotechnology or pharma company.[1][5][6][7][11]

Industry: Investors

Beyond the preview

Go deeper on SIS Ventures Impact Investors.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SIS Ventures Impact Investors.

Explore the full profile